This lab, in collaboration with the lab of Ruben Shaw at the Salk Institute, recently identified SBI - 0206965, the first potent and
selective small molecule inhibitor of ULK1, a serine / threonine kinase that is a critical regulator of autophagy.
Not exact matches
The company's therapeutic candidates are highly
selective sodium ion channel 1.7 (Naᵥ1.7)
inhibitors based on naturally occurring
small molecules.
We have used a variety of cell models to test toxicity, cell penetration, and efficacy of furin
inhibitors, and have identified
small molecule inhibitors selective for cell surface furin action as well as
inhibitors which also work intracellularly.